Recently, it has been shown that an antibody against the negative regulatory region (NRR) of Notch1 resulted in reduced proliferation, restricted expression of its targets HES1, HES5, and HEY-L, reduced colony forming ability, and lessened cancer stem-like population in MDA-MB-231 cell lines [156]. Here, NOTCH1 is linked to cancer.